A 76-year-old woman presented with catatonia, refusal to eat due to delusion, and visual hallucination. Single photon emission computed tomography showed remarkable occipital hypoperfusion and frontal hyperperfusion.
Introduction
Symptoms of dementia with Lewy bodies (DLB) consist of dementia and parkinsonism. Compared with Alzheimer's disease, patients with DLB show severe visual hallucination and delusion. Neuroimaging using single photon emission tomography (SPECT) or positron emission tomography is useful for the differential diagnosis between Alzheimer's disease and DLB. Hypometabolism and hypoperfusion in the occipital lobe is a characteristic feature of DLB (1) . Neurolepic supersensitivity sometimes makes it difficult to treat these symptoms (2) . Some studies have shown the usefulness of the acetylcholinesterase inhibitor donepezil on psychiatric symptoms in DLB (3) (4) (5) . We herein present a woman with probable DLB who showed catatonia and refusal to eat. We treated her with amitriptyline and lorazepam, which dramatically improved her symptoms and normalized occipital cerebral blood flow.
Case Report
A right-handed 76-year-old woman was admitted to our hospital from another hospital to treat motor and psychiatry symptoms. She had experienced resting tremor at the age of 72. She had been treated with anti-parkinsonian drugs. Within three years, she had complained that some insects developed in her stomach and that she was chased by a large snake. Since she had attempted to remove the insects from her stomach with a scissors and a knife, she was admitted to hospital. She had been treated with strong tranquilizers including chlorpromazine/CPZ or quetiapine. In addition, Yi-Gan San and donepezil had been tried but there had been no effect on psychosis. Since she refused to eat and showed severe akinesia, she was transferred to our hospital. She had been treated with donepezil (5 mg), quetiapine (150 mg), l-dopa/benserazide (100 mg), amlodipine (2.5 mg), candesartan cilexetil (4 mg), and trichlormethiazide (0.5 mg). She had a past history of osteomyelitis at the age of nine, and she could not attend further elementary school education since that time. She was not good at reading or writing.
Her body temperature was 36.7 . Blood pressure was 160/95 mmHg, and pulse rate was 60/m. Her skin was wet due to mild sweating. She was bedridden and mute. She could obey simple oral commands. On neurological examination, external eye movement was normal and nystagmus was not seen. Her face was oily and masked. The tongue was normal appearance. There was not dysphagia. All limbs were in flexion posture. She showed motiveless resistance to maintenance of rigid posture against attempts to be moved, suggesting catatonic rigidity. Resting tremor was observed in them. Deep tendon reflex was all normal. There was no pathological reflex. Detailed sensory examination, coordination, and cognitive examination was impossible.
Laboratory findings were normal except for a high level of LDL-cholesterol. Plasma creatine kinase was 44 IU/L. Thyroid function was normal and GAD antibody was negative. Temporal and occipital lobes were not atrophic on magnetic resonance imaging (MRI). Electroencephalogram (EEG) showed low amplitude 8 c/s alpha waves in the occipital region. Myocardial scintigraphy using 123 I metaiodobenzyl guanidine (MIBG) showed a decreased uptake (early phase H/M 1.62, delayed phase H/M 1.34).
Quetiapine was decreased to 75 mg/day on the admission day. Since psychosis was not deteriorated, quetiapine was discontinued. Donepezil was also stopped since there is a case report stating that donepezil could cause catatonia (6) . SPECT using 123 I-N-isopropyl-P-iodoamphetamine revealed remarkable hypoperfusion in the bilateral occipital lobes and hyperperfusion in the bilateral frontal lobes (Fig. 1A) . She did not eat foods because she was afraid that insects in her body develop. Nasogastric tube was inserted to start tube nutrition. Drip infusion test of l-dopa was performed as previously reported (7). However, intravenous infusion of ldopa had no effect on her motor dysfunction. Subsequently, oral administration of l-dopa/carbidopa was started and gradually increased up to 500 mg/day, which also resulted in failure. A case report which showed modifiedelectroconvulsive therapy (m-ECT) improved psychosis and occipital hypoperfusion in a single DLB patient (8) encouraged us to use antidepressant. Amitriptyline was administered at the initial dose of 10 mg/day to 20 mg/day. After two weeks from administration of amitriptyline, she began to speak spontaneously. Catatonic rigidity was also improved. The dose of amitriptyline was elevated to 60 mg/day and lorazepam was added orally from then at the dose of 1.5 mg/day. Further two weeks later, she asked us to take a nasogastric tube off and declared to eat foods. The dose of lorazepam was decreased to 0.5 mg/day due to daily sleepiness. She recovered to be able to eat foods with chopsticks and sometimes she talked with smiling. Cogwheel-like rigidity remained in her arms, but resting tremor was hardly seen. There was no nocturnal cry. Visual hallucination and delusion became minimal, and they did not disturb her daily life. Revised version of Hasegawa dementia scale which does not require reading or writing showed 14/30, which suggested that she has some type of dementia. The second SPECT showed marked improvement of perfusion of the frontal and occipital lobes (Fig. 1B) . Cerebral blood flow of the frontal and occipital lobes was assessed to be normal when analyzed with easy Z-score Imaging System (9) (Fig. 2) . The amplitude and frequency of alpha waves was increased in EEG. The clinical course is shown in Fig. 3 .
Discussion
The patient was diagnosed as having probable DLB or Parkinson's disease with dementia (PDD) according to the diagnostic criteria (10) . Results of SPECT and MIBG myocardial scintigraphy supported the diagnosis. Although the adverse effect of quetiapine could not be ruled out, her motor dysfunction was thought to be catatonia. Catatonia is diagnosed when there are at least two out of five major symptoms; motoric immobility, excessive motor activity, extreme negativism, peculiarities of voluntary movements, and echolalia/echopraxia (11) . She showed motoric immobility and extreme negativism. Catatonia is thought to be caused by not only schizophrenia but also emotional disorders or general diseases (11) . Catatonia in DLB patients have also been reported (6, 12, 13) . Catatonia in the present case was thought to be associated with depression which sometimes complicates DLB. A pharmacological approach to the psychiatric symptoms in DLB is sometimes difficult due to neu- Nasogastric tubing roleptic supersensitivity. Although the acetylcholinesterase inhibitor donepezil (3) (4) (5) , quetiapine (14) and Yi-Gan San (15) were reported to be beneficial on psychiatric symptoms in DLB, all of them were not effective in this case. We first administered amitriptyline to this patient. Amitriptyline dramatically improved catatonia and psychiatric symptoms. Although we added low-dose lorazepam with amitriptyline, her symptoms began to improve before administration of lorazepam. There have been no large clinical trials on the effectiveness of antidepressants in DLB. Visual hallucination was reported to be improved with the selective serotonin reuptake inhibitor paroxetine in two patients (16) . Neurochemical studies showed reductions in cortical serotonin (5-HT) terminals in DLB, indicated by lower levels of both 5-HT and 5-hydroxyindole-3-acetic acid (17, 18) . Both amitriptyline and paroxetine enhance synaptic 5-HT effects. The present case suggests that an antidepressant might be effective for psychiatric symptoms in some DLB patients. In addition to the clinical symptoms, occipital lobe hypoperfusion seemed to be normalized. The mechanism of occipital lobe hypometabolism and hypoperfusion in DLB remains to be clarified. Pathological study revealed that the density of Lewy bodies was the lowest in the occipital lobes (19) . Taken together, our case and the patient treated with m-ECT (8) suggest that occipital lobe hypoperfusion might not be due to neurodegenerative changes but rather it is functional and reversible. Furthermore, occipital lobe hypoperfusion could be a marker of treatments in DLB. Although donepezil has been reported to increase occipital cerebral blood flow, the magnitude of the increase was limited to approximately 3 mls/min (20) . As far as we know, there is no report which showed normalization of occipital cerebral blood flow in DLB with some treatment except for m-ECT therapy (8) . Recently, frontal hyperperfusion was observed in DLB patients with delusion (21) . In the present case, this abnormality was also improved.
In summary, although further study is needed to clarify whether the hypoperfusion of occipital lobes in DLB might be reversible or not, catatonia responsive to antidepressants or lorazepam should not be overlooked even in patients who appear to have an advanced stage of dementia (22) .
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